ACIP Evidence to Recommendations for Use of Nirsevimab in Children 8–19 Months of Age at Increased Risk of Severe Disease Entering Their Second RSV Season

• 2024

  Log in to bookmark this resource.

  Log in

---

Access Resources

• SummaryEN
• Ask aRCie About This Resource

About

This webpage provides evidence for the recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the use of nirsevimab for a population of children (8-19 months old) who present higher risk for severe disease entering their second RSV season. The Evidence to Recommendations (EtR) frameworks explain the information used when making ACIP vaccine recommendations.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Child; Cystic Fibrosis; Neuromuscular Diseases; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Risk; Immunocompromised Host; Vulnerable Populations; Antibodies, Monoclonal, Humanized

Institutions: Centers for Disease Control and Prevention (CDC)

---

More like this

Fact Sheet: United States Response to the Clade I Mpox Outbreak in Several African Countries 2024 · Centers for Disease Control and Prevention (CDC) Meeting Summary: State and Local Implementation Strategies for Increasing Access to Contraception During Zika Preparedness and Response — United States, September 2016 2017 · Centers for Disease Control and Prevention (CDC), Association of Schools & Programs of Public Health Interim Clinical Considerations for Use of Vaccine for Monkeypox Prevention in the United States 2025 · Centers for Disease Control and Prevention (CDC)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---